Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
---|
06/06/2007 | CN1976699A Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
06/06/2007 | CN1974568A Prepn process of aztreonam |
06/06/2007 | CN1974562A Cycloprothrin amide compound containing quinary nitrogen heterocycle ketone and its prepn and application |
06/06/2007 | CN1974561A Cyhalothrin amide compound containing quinary nitrogen heterocycle ketone and its prepn and application |
06/06/2007 | CN1319967C 2-acylaminothiazole derivative or salt thereof |
06/06/2007 | CN1319956C Thiazolidine diketone derivatives, preparing process and application of pharmaceutical preparations of the same |
06/06/2007 | CN1319955C Moguisteine crystallographic form |
06/05/2007 | US7227022 Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase |
06/05/2007 | US7226940 Such as 3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-methoxybenzylidene-2,4-thiazolidinedione; Hodgkin's disease |
06/05/2007 | CA2225624C Hydrazine derivatives |
05/31/2007 | WO2007062342A1 Heterocyclic cetp inhibitors |
05/31/2007 | WO2007062308A2 Homo- and heterocyclic compounds suitable as cetp inhibitors |
05/31/2007 | WO2007061661A2 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
05/31/2007 | WO2007061600A1 CATALYZED PROCESS OF MAKING C-5-SUBSTITUTED HETEROCYCLIC INHIBITORS OF 11ß-HYDROXY STEROID DEHYDROGENASE TYPE 1 |
05/31/2007 | WO2007061094A1 Pharmaceutical comprising ppar agonist |
05/31/2007 | WO2007060526A1 Substituted azacycloalkanes useful for treating cns conditions |
05/31/2007 | WO2007060166A1 New n-phenethylcarboxamide derivatives |
05/31/2007 | WO2007060164A1 N-(1-alkyl-2-phenylethyl)-carboxamide derivatives and use thereof as fungicides |
05/31/2007 | WO2007060121A1 Indanyl-and tetrahydronaphthyl-amino-azoline compounds for combating animal pests |
05/31/2007 | WO2007037543A9 Biarylamide derivative |
05/31/2007 | WO2007030618A3 Bicyclic derivatives as modulators of voltage gated ion channels |
05/31/2007 | WO2007019251A3 Sphingosine kinase inhibitors and methods of their use |
05/31/2007 | WO2006058700A8 Acetamide compounds as fungicides |
05/31/2007 | WO2005108383A3 Multi-lamellar liquid crystal emulsion system |
05/31/2007 | US20070123573 Process for the preparation of biologically active tetrahydrobenzthiazole derivative |
05/31/2007 | US20070123523 Inhibitors of cathepsin s |
05/31/2007 | US20070123493 Benzamide derivative |
05/31/2007 | CA2630816A1 Pharmaceutical comprising ppar agonist |
05/31/2007 | CA2630718A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
05/31/2007 | CA2630558A1 Catalyzed process of making c-5-substituted heterocyclic inhibitors of 11.beta.-hydroxy steroid dehydrogenase type 1 |
05/31/2007 | CA2630459A1 Substituted azacycloalkanes useful for treating cns conditions |
05/31/2007 | CA2630234A1 Thrombopoietin activity modulating compounds and methods |
05/31/2007 | CA2629935A1 (r)-arylalkylamino derivatives and pharmaceutical compositions containing them |
05/31/2007 | CA2628538A1 Indanyl-and tetrahydronaphthyl-amino-azoline compounds for combating animal pests |
05/30/2007 | EP1789407A2 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
05/30/2007 | EP1789406A1 Thioxothiazolidinone compounds for use as pharmaceuticals |
05/30/2007 | EP1789381A2 Inhibitors of histone deacetylase |
05/30/2007 | EP1789040A2 Halogenated benzamide derivatives |
05/30/2007 | EP1709014B1 Antidiabetic oxazolidinediones and thiazolidinediones |
05/30/2007 | EP1429763B1 NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER |
05/30/2007 | EP1248615B1 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
05/30/2007 | EP1003730B1 2-benzoyl-cyclohexane-1,3-diones |
05/30/2007 | EP0914605B1 Molecular model for vla-4 inhibitors |
05/30/2007 | CN1972897A Novel hexafluoroisopropanol derivatives |
05/30/2007 | CN1970547A Novel febuxostat crystal form and its preparation method |
05/30/2007 | CN1318422C Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics |
05/29/2007 | US7223868 Heteroaromatic glucokinase activators |
05/29/2007 | US7223760 Substituted triazole compounds |
05/29/2007 | US7223355 Functional additive having UV-absorbing substituent and ink composition containing the same |
05/24/2007 | WO2007059157A1 Bisamide inhibitors of hedgehog signaling |
05/24/2007 | WO2007058482A1 Novel inhibitors of protein kinase |
05/24/2007 | WO2007057139A1 Microbiocides |
05/24/2007 | WO2007057128A1 Novel dual peptidase inhibitors as prodrugs for the therapy of inflammatory and other disorders |
05/24/2007 | US20070117853 (+)-3-acetyl-6-chloro-2-[2-(3-(N-(2-hydroxyethyl)-N-isopropylamino)propoxy)-5-methoxyphenyl]benzothiazoline; kappa -opioid receptor agonist |
05/24/2007 | US20070117852 (Hetero)cyclyl carboxanilides for controlling harmful fungi |
05/24/2007 | US20070117812 3,5-Difluoro-2-pyridinecarboxamidine; intermediate for preparing dihydropyrimidines for the treatment and prophylaxis of hepatitis B |
05/24/2007 | US20070117807 Potassium channel modulators; cardiovascular disorders; antiarrhythmia agents; synthesis |
05/24/2007 | US20070117797 Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity |
05/24/2007 | CA2629814A1 Bisamide inhibitors of hedgehog signaling |
05/24/2007 | CA2628145A1 Novel dual-use peptidase inhibitors as prodrugs for a therapy of inflammatory and other disorders |
05/23/2007 | EP1787986A1 Hydroxamic acid derivative and medicine containing the same as active ingredient |
05/23/2007 | EP1787981A1 New N-phenethylcarboxamide derivatives |
05/23/2007 | EP1786795A2 Biphenyl thiazole carboxamides |
05/23/2007 | EP1786794A2 Biphenyl-thiazolo-carboxamides |
05/23/2007 | EP1786793A1 Tertiary amine salts of 2-(2-aminothiazole-4-yl)-2-(acyloxyimino)acetic acid |
05/23/2007 | EP1786792A2 Thiazole derivatives having vap-1 inhibitory activity |
05/23/2007 | EP1786790A1 Oxazole derivatives as histamine h3 receptor agents, preparation and therapeutic uses |
05/23/2007 | EP1786768A1 Arylsulphonylstilbene derivatives for treatment of insomnia and related conditions |
05/23/2007 | EP1654213B1 Matrix metalloproteinase inhibitors |
05/23/2007 | EP1562923B1 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
05/23/2007 | EP1369419B1 N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same |
05/23/2007 | EP1254895B1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
05/23/2007 | EP1212619B1 Substrates and screening methods for transport proteins |
05/23/2007 | CN1969205A 滤光片及花青化合物 Filters and anthocyanin compounds |
05/23/2007 | CN1968938A Method for preparing thiazole by aminomethylation |
05/23/2007 | CN1317265C Cyanoacrylate derivatives and their preparation method and biological activity |
05/22/2007 | US7220880 For therapy of diabetes mellitus, cardiovascular disease, obesity, Syndrome X and gastrointestinal disease, such as, inflammatory bowel disease |
05/22/2007 | US7220864 Peroxisome proliferator activator controller; dietetics; antidiabetic agents; cardiovascular disorders; antidiabetic agents; hypoglycemic agents; antilipemic agenst |
05/22/2007 | US7220781 Meta-benzamidine derivatives as serine protease inhibitors |
05/22/2007 | US7220765 have a good affinity for certain subtypes of somatostatin receptors and have useful pharmacological properties |
05/22/2007 | US7220752 Liver selective glucocorticoid receptor antagonists; lowering blood glucose levels; 3,5-dibromo-4-(5-isopropyl-2-(3-methylbenzoyl)-4-(3-methyl-3-b utenyloxy)phenoxy)-phenylacetic acid for example |
05/22/2007 | US7220745 Viricides; therapy for hepatitis virus infections |
05/22/2007 | CA2436863C Process and ester derivatives useful for preparation of cephalosporins |
05/22/2007 | CA2382573C Substituted benzylthiazolidine-2,4-dione derivatives |
05/22/2007 | CA2368347C Glucokinase activators |
05/18/2007 | WO2007056496A1 Oxazole and thiazole ppar modulator |
05/18/2007 | WO2007056469A2 Certain chemical entities, compositions, and methods |
05/18/2007 | WO2007056366A2 Compounds and compositions as ppar modulators |
05/18/2007 | WO2007029037A3 Class iia histone deacetylase (hdac) substrate |
05/18/2007 | WO2007029036A3 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
05/18/2007 | WO2007029035A3 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
05/18/2007 | WO2007003944A3 Compounds for imaging and therapy |
05/18/2007 | CA2626483A1 Compounds and compositions as ppar modulators |
05/18/2007 | CA2626443A1 Oxazole and thiazole ppar modulators |
05/17/2007 | US20070112216 Method for producing chiral mercapto amino acids |
05/17/2007 | US20070112007 Cyclohexyl-1, 4-diamine compounds |
05/17/2007 | US20070112002 1-[2-(4,4-dimethylcyclohexyl)-5-methoxyphenyl]-4-pentylpiperazine; excellent cell adhesion inhibitory action or cell infiltration inhibitory action; inflammatory diseases and autoimmune diseases such as ulcerative colitis, Crohn's disease, irritable bowel syndrome, rheumatoid arthritis, psoriasis, asthma |
05/16/2007 | EP1785134A2 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
05/16/2007 | EP1784394A1 Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression |
05/16/2007 | EP1784386A2 Histone deacetylase inhibitors |